Basiliximab significantly reduces acute rejection in renal transplant patients given triple therapy with azathioprine. [electronic resource]
Producer: 20010628Description: 1009-10 p. digitalISSN:- 0041-1345
- Acute Disease
- Adolescent
- Adult
- Aged
- Anti-Inflammatory Agents -- therapeutic use
- Antibodies, Monoclonal -- therapeutic use
- Azathioprine -- therapeutic use
- Basiliximab
- Cyclosporine -- therapeutic use
- Drug Therapy, Combination
- Female
- Graft Rejection
- Humans
- Immunosuppressive Agents -- therapeutic use
- Infections -- etiology
- Kidney Transplantation -- immunology
- Male
- Middle Aged
- Postoperative Complications -- etiology
- Prednisone -- therapeutic use
- Recombinant Fusion Proteins
No physical items for this record
Publication Type: Clinical Trial; Journal Article; Multicenter Study; Randomized Controlled Trial
There are no comments on this title.
Log in to your account to post a comment.